Iron supplementation in early infancy
Phase 3
- Registration Number
- CTRI/2019/04/018460
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All appropriate for gestational age exclusively breast fed apparently healthy term infants at 90-120days of age with hemoglobin >10.5gm/dl and MCV of 78fl.
Exclusion Criteria
Infants with congenital anomalies or genetic syndromes. Infants on iron supplementation already
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine whether initiation of supplemental iron at 90-120 days of age in apparently healthy exclusively breast term appropriate for gestational age infants prevent the development of IDA at 6months of age.Timepoint: To determine whether initiation of supplemental iron at 90-120 days of age in apparently healthy exclusively breast term appropriate for gestational age infants prevent the development of IDA at 6months of age.
- Secondary Outcome Measures
Name Time Method . To determine the efficacy of iron supplementation in preventing the development of iron depletion at 6months of age. <br/ ><br>2.To determine the efficacy of iron supplementation in preventing the development of iron deficient erythropoiesis at 6months of age. <br/ ><br>3.To evaluate the change in hemoglobin, ferritin and transferrin saturation levels between the age 90 to 120 days and 6 months.Timepoint: 6 months of age